Diabetes groups call for better regulation of insulin pumps

Regulatory agencies should adopt a more rigorous, standardised approach to assessing the safety of insulin pumps and require manufacturers to provide safety data during development and throughout clinical use, suggest leading diabetes organisations in new recommendations to reduce adverse events ...